Top Markets
Coin of the day
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Rang in aandelen #41089
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Aandeelprijs
$0.0202
Laatst gesynchroniseerd: 2024-11-19
Marktkapitalisatie
$44.67K
Verandering (1 dag)
-0.49%
Verandering (1 jaar)
0.00%
Land
IL
Handel Notable Labs, Ltd. (NTBL)

Categorie

Winst voor Notable Labs, Ltd. (NTBL)
Winst in Jun 2024 TTM: $-8.99M
Volgens de meest recente financiële verslagen van Notable Labs, Ltd. bedraagt de huidige winst van het bedrijf $-8.99M. In 2022 behaalde het bedrijf een winst van $-14.41M, een stijging ten opzichte van de winst van 2021, die $-16.05M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Notable Labs, Ltd. van 2015 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
2026 (TTM) $-8.99M -20.23%
2023 $-11.26M -21.82%
2022 $-14.41M -10.25%
2021 $-16.05M -33.74%
2020 $-24.23M 24.90%
2019 $-19.40M -5.19%
2018 $-20.46M 101.80%
2017 $-10.14M -36.65%
2016 $-16.00M 7.48%
2015 $-14.89M 0.00%
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
$5.27B -58,807.85%
US
$1.95B -21,810.07%
NL
- -
CH
- -
KR
$3.01B -33,552.61%
BE